OR WAIT null SECS
Better data-sharing for cellular and genetic therapies is the goal
Having established partnerships with World Courier and Deloitte recently, Vineti has now formed another one with Quick Specialized Healthcare Logistics, part of the Quick International express-delivery firm. Vineti, based in San Francisco, has recently emerged as one of a handful of companies providing a digital "platform of record" for next-generation therapies that aligns, tracks, and documents the entire cell therapy process, from ordering and logistics to manufacturing and clinical data. According to Amy DuRoss, Vineti co-founder and CEO, the Quick collaboration will enable logistics data to flow smoothly between the two companies, enabling biopharma companies in clinical trials or early-stage commercialization to collect and monitor product data.
Cellular and genetic therapies (CGTs), such as those involving CAR-T technology, usually involve extracting cells from a patient, conveying it to a facility where the genetic manipulations are performed, and then returning it to the patient for infusion. “CGTs represent the time that GMP-based processes originate in the clinic,” notes DuRoss. “Our value proposition is to provide a system of record for the entire process.”
Quick and Vineti accompanied the partnership announcement with release of a “tip sheet” for managing CGT processes, available at the Vineti website. “Plan your first mile as carefully as your last. In CGT, your logistics, Chain of Identity, Chain of Custody, and GMP manufacturing start at sample collection. When a patient is the product, every step in the journey matters. Plan and orchestrate every mile with precision,” is one of the recommendations.